• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

FDA to discuss experimental drug’s effectiveness against anthrax
by Mary J. Lewis on October 26, 2009

A Human Genome Sciences Inc. drug worked better than a placebo but similar to antibiotics for treating anthrax exposure in animal studies, U.S. drug reviewers said in a summary released Oct. 23.

N.H. agencies take part in terror event drill
by Ted Purlain on October 20, 2009

The New Hampshire Department of Human Services asked all health regions to respond to a training scenario where there was a deliberate terrorist release of the biological agent anthrax.

Albany Medical College to fund biodefense research of tularemia
by Mary J. Lewis on October 18, 2009

ALBANY, N.Y. — Albany Medical College has been awarded a $4.6 million grant to fund its biodefense research against Francisella tularensis, the bacteria that causes tularemia.

PanThera Biopharma gets $1.6 million contract for botulism antidote research
by Mary J. Lewis on October 16, 2009

HONOLULU — PanThera Biopharma announced the award of a one-year, $1.6 million contract from the Department of Defense to advance the company's research of antidote for botulism.

New York prepares response to anthrax attack
by Paul Tinder on September 14, 2009

NEW YORK – The City’s Department of Health tested its readiness to respond to an anthrax attack with an antibiotics and vaccine distribution drill this week at a Lower East Side school.

Lieberman laments state of preparedness
by Rita Uplend on September 14, 2009

Sen. Joseph Lieberman (I-Conn.) is chairman of the Senate Homeland Security Committee. He spoke to BioTerrorWatch about the need to make the United States safer from the threat of weapons of mass destruction.

Emergent BioSolutions submits development plan for anthrax vaccine
by Ted Purlain on September 14, 2009

ROCKVILLE, Md -- Emergent BioSolutions Inc. has submitted a development plan to the FDA for its Recombinant Protective Antigen (rPA) anthrax vaccine candidate.

Two-day training session simulates pneumonic plague attack
by Paul Tinder on September 14, 2009

GENEVA – Members of US humanitarian aid groups learned how to deter biological terrorist attacks during a recent two-day training session in Montreux, Switzerland.